Reaction Details  Report a problem with these data
Target
Glucagon receptor
Ligand
BDBM50007237
Substrate
n/a
Meas. Tech.
ChEMBL_1338727 (CHEMBL3242198)
IC50
230±n/a nM
Citation
 DeMong, D; Dai, X; Hwa, J; Miller, M; Lin, SI; Kang, L; Stamford, A; Greenlee, W; Yu, W; Wong, M; Lavey, B; Kozlowski, J; Zhou, G; Yang, DY; Patel, B; Soriano, A; Zhai, Y; Sondey, C; Zhang, H; Lachowicz, J; Grotz, D; Cox, K; Morrison, R; Andreani, T; Cao, Y; Liang, M; Meng, T; McNamara, P; Wong, J; Bradley, P; Feng, KI; Belani, J; Chen, P; Dai, P; Gauuan, J; Lin, P; Zhao, H The discovery of N-((2H-tetrazol-5-yl)methyl)-4-((R)-1-((5r,8R)-8-(tert-butyl)-3-(3,5-dichlorophenyl)-2-oxo-1,4-diazaspiro[4.5]dec-3-en-1-yl)-4,4-dimethylpentyl)benzamide (SCH 900822): a potent and selective glucagon receptor antagonist. J Med Chem 57:2601-10 (2014) [PubMed]  Article
Target
Name:
Glucagon receptor
Synonyms:
GCGR | GL-R | GLR_HUMAN | Glucagon Receptor (GCGR) | Glucagon receptor (GlucR)
Type:
Enzyme
Mol. Mass.:
54026.92
Organism:
Homo sapiens (Human)
Description:
P47871
Residue:
477
Sequence:
MPPCQPQRPLLLLLLLLACQPQVPSAQVMDFLFEKWKLYGDQCHHNLSLLPPPTELVCNRTFDKYSCWPDTPANTTANISCPWYLPWHHKVQHRFVFKRCGPDGQWVRGPRGQPWRDASQCQMDGEEIEVQKEVAKMYSSFQVMYTVGYSLSLGALLLALAILGGLSKLHCTRNAIHANLFASFVLKASSVLVIDGLLRTRYSQKIGDDLSVSTWLSDGAVAGCRVAAVFMQYGIVANYCWLLVEGLYLHNLLGLATLPERSFFSLYLGIGWGAPMLFVVPWAVVKCLFENVQCWTSNDNMGFWWILRFPVFLAILINFFIFVRIVQLLVAKLRARQMHHTDYKFRLAKSTLTLIPLLGVHEVVFAFVTDEHAQGTLRSAKLFFDLFLSSFQGLLVAVLYCFLNKEVQSELRRRWHRWRLGKVLWEERNTSNHRASSSPGHGPPSKELQFGRGGGSQDSSAETPLAGGLPRLAESPF
  
Inhibitor
Name:
BDBM50007237
Synonyms:
CHEMBL3238224
Type:
Small organic molecule
Emp. Form.:
C35H47N7O3
Mol. Mass.:
613.7928
SMILES:
COc1cccc(c1)C1=N[C@@]2(CC[C@@H](CC2)C(C)(C)C)N([C@H](CCC(C)(C)C)c2ccc(cc2)C(=O)NCc2nn[nH]n2)C1=O |r,wU:13.17,21.23,wD:10.11,t:9,(60.9,-33.41,;60.14,-32.07,;58.6,-32.06,;57.83,-30.72,;56.29,-30.71,;55.52,-32.04,;56.28,-33.38,;57.82,-33.39,;55.5,-34.71,;53.96,-34.77,;53.54,-36.25,;52.36,-35.26,;50.91,-35.79,;50.65,-37.31,;51.83,-38.3,;53.28,-37.76,;49.21,-37.84,;48.02,-36.86,;47.76,-38.38,;48.95,-39.36,;54.82,-37.11,;54.88,-38.64,;53.55,-39.43,;53.57,-40.97,;52.25,-41.75,;52.27,-43.29,;50.9,-41,;50.91,-42.51,;56.2,-39.43,;56.18,-40.97,;57.51,-41.76,;58.85,-41.01,;58.87,-39.47,;57.55,-38.68,;60.18,-41.8,;60.15,-43.34,;61.51,-41.04,;62.84,-41.83,;64.18,-41.07,;65.58,-41.71,;66.62,-40.58,;65.87,-39.24,;64.36,-39.54,;56.03,-36.16,;57.51,-36.57,)|
Structure:
Search PDB for entries with ligand similarity: